ERBB2 and gastric cancer: Upregulation of miR-223 decreased FBXW7 expression and subsequently reduced the sensitivity of HER2-positive GC cell lines to trastuzumab, thereby acting as an oncomiR and suppressing trastuzumab-induced apoptosis.